Education
About Us
Working with TipRanks
Follow Us
Ainos (AIMD)
NASDAQ:AIMD
AIMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.00 - $5.00
Previous CloseN/A
Volume220.33K
Average Volume (3M)4.79M
Market Cap
$13.62M
Enterprise Value$17.16M
Total Cash (Recent Filing)$2.63M
Total Debt (Recent Filing)$12.00M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Nov 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,192,041
10 Day Avg. Volume14,219,596
30 Day Avg. Volume4,792,113
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue161.61
Enterprise Value/Gross Profit276.24
Enterprise Value/Ebitda-1.47
Forecast
1Y Price Target
$3.50Price Target Upside4.17% Upside
Rating ConsensusHold
Number of Analyst Covering1
Ainos News
AIMD FAQ
What was Ainos’s price range in the past 12 months?
Ainos lowest stock price was $2.00 and its highest was $5.00 in the past 12 months.
What is Ainos’s market cap?
Ainos’s market cap is $13.62M.
When is Ainos’s upcoming earnings report date?
Ainos’s upcoming earnings report date is Nov 05, 2025 which is in 82 days.
How were Ainos’s earnings last quarter?
Currently, no data Available
Is Ainos overvalued?
According to Wall Street analysts Ainos’s price is currently Undervalued.
Does Ainos pay dividends?
Ainos does not currently pay dividends.
What is Ainos’s EPS estimate?
Ainos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ainos have?
Ainos has 4,192,041 shares outstanding.
What happened to Ainos’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ainos?
Currently, no hedge funds are holding shares in AIMD
Ainos Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.50 (4.17% Upside)
$3.50 (4.17% Upside)
Insider Transactions
Sold Shares
Worth $23.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 38.6%
Last 30 Days ▲ 25.2%
Last 30 Days ▲ 25.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.19%
12-Months-Change
Fundamentals
Return on Equity
-82.87%
Trailing 12-Months
Asset Growth
-11.43%
Trailing 12-Months
Company Description
Ainos
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
AIMD Stock 12 Month Forecast
Average Price Target
$3.50
▲(4.17% Upside)
Technical Analysis
Ibio
―
Kiora Pharmaceuticals
―
Aprea Therapeutics
―
Evaxion Biotech
―
Acurx Pharmaceuticals
―
Ownership Overview
27.01% Insiders
0.13% Mutual Funds
0.08% Other Institutional Investors
72.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---